Blueprint Medicines Quote - 0HOJ

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

82.54

Bid

0.00

Ask

0.00

Volume

0.00 Day's Range 0.00

82.54 52 Week Range 82.54

Market Cap

5.243B

Previous Close

82.54

Open

Last Trade

90.13

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

222

Shares Outstanding

63,526,000

Dividend Yield

PE Ratio

-84.76

Earnings Per Share (EPS)

-1.06

Revenue

508.82M

Net Profit

-67.09M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.blueprintmedicines.com

Headquarters

Wilmington, Delaware, USA

Founded

Blueprint Medicines Corp is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0HOJ. The last closing price for Blueprint Medicines was US$82.54. Over the last year, Blueprint Medicines shares have traded in a share price range of US$ 82.54 to US$ 82.54.

Blueprint Medicines currently has 63,526,000 shares outstanding. The market capitalization of Blueprint Medicines is US$5.24 billion. Blueprint Medicines has a price to earnings ratio (PE ratio) of -84.76.

No news to show yet.

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	82.54	82.54	82.54	92	82.54	DE
4	82.54	82.54	82.54	60	82.54	DE
12	82.54	82.54	82.54	222	82.54	DE
26	82.54	82.54	82.54	286	82.54	DE
52	82.54	82.54	82.54	224	82.54	DE
156	82.54	82.54	82.54	115	82.54	DE
260	82.54	82.54	82.54	103	82.54	DE

0HOJ - Frequently Asked Questions (FAQ)

What is the current Blueprint Medicines share price?

The current share price of Blueprint Medicines is US$ 82.54

How many Blueprint Medicines shares are in issue?

Blueprint Medicines has 63,526,000 shares in issue

What is the market cap of Blueprint Medicines?

The market capitalisation of Blueprint Medicines is USD 5.24B

What is the 1 year trading range for Blueprint Medicines share price?

Blueprint Medicines has traded in the range of US$ 82.54 to US$ 82.54 during the past year

What is the PE ratio of Blueprint Medicines?

The price to earnings ratio of Blueprint Medicines is -84.76

What is the cash to sales ratio of Blueprint Medicines?

The cash to sales ratio of Blueprint Medicines is 11.18

What is the reporting currency for Blueprint Medicines?

Blueprint Medicines reports financial results in USD

What is the latest annual turnover for Blueprint Medicines?

The latest annual turnover of Blueprint Medicines is USD 508.82M

What is the latest annual profit for Blueprint Medicines?

The latest annual profit of Blueprint Medicines is USD -67.09M

What is the registered address of Blueprint Medicines?

The registered address for Blueprint Medicines is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the Blueprint Medicines website address?

The website address for Blueprint Medicines is www.blueprintmedicines.com

Which industry sector does Blueprint Medicines operate in?

Blueprint Medicines operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GCMGcm Resources Plc	2.80p (47.37%)	7.51M
SNGSynairgen Plc	1.26p (40.00%)	2.09M
THRUThruvision Group Plc	0.90p (38.46%)	10.74M
NARFNarf Industries Plc	0.45p (38.46%)	18.45M
XTRXtract Resources Plc	0.90p (28.57%)	12.34M
ENETEthernity Networks Ltd	0.0425p (-32.00%)	250.35M
BIOMBiome Technologies Plc	1.00p (-20.00%)	863.66k
PYXPyx Resources Limited	1.60p (-17.74%)	415.36k
ADMEAdm Energy Plc	0.25p (-16.67%)	1.04M
SYMESupply@me Capital Plc	0.003p (-14.29%)	188.86M
PREMPremier African Minerals Limited	0.01175p (12.98%)	1.45B
CPAICapai Plc	0.135p (14.89%)	1B
UKOGUk Oil & Gas Plc	0.011p (4.76%)	350.88M
ENETEthernity Networks Ltd	0.0425p (-32.00%)	250.35M
EMEEmpyrean Energy Plc	0.11p (-10.20%)	191.13M